For Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership in global COVID-19 vaccine distribution, along with robust supply chain efficiencies, Indian firms are strategically positioned to capitalize on this market shift. The departure of Chinese players from the market opens a significant gap, which Indian companies are well-equipped to fill .
Radhakishan Damani sells 1 lakh shares in VST Industries for Rs 4.4 crore via block deal
Ace investor Radhakishan Damani has sold 1 lakh shares in VST Industries for Rs 4.4 crore via a block deal. The shares were sold at